Norway· NO-ID_D411175A-E6FB-4420-A5BD-C324148577B1
Dapson scanpharm
A dapsone product containing dapsone, registered in Norway by Scanpharm. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Dapsone is registered in 10 of 19 countries.
Countries holding a registration under ATC J04BA02 (dapsone), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 4 of them publish a price we can compare per daily dose
Dapsone · ATC J04BA02
10 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Dapsone
- Manufacturer
- Scanpharm
- Country
- Norway (NO)
- ATC code
- J04BA02
- ATC class
- Dapsone
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_D411175A-E6FB-4420-A5BD-C324148577B1
- no_varenummer265082100
- gtin5707990160015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for dapsone.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dapsone · interactions on record
415 records
- 7 severe
- 206 moderate
- 2 minor
- 200 info
Most severe, free to view
- SaquinavirJ05AE01severe
- CladribineL01BB04severe
- Aminolevulinic acidL01XD04severe
- CladribineL04AA40severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dapsone in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDapsone 50mg tabletsDr Reddy's Laboratories (UK) Ltd
- PolandDusalmAdamed Pharma S.A.
- United StatesAczoneAlmirall, LLC
- CanadaACZONEBAUSCH HEALTH, CANADA INC.
- GermanyDapson ZentivaZentiva Pharma Gmbh
- SpainSULFONA COMPRIMIDOSEsteve Pharmaceuticals S.A.
- Japanジアフェニルスルホン田辺ファーマ
- NetherlandsDapson Tiofarma 100 mg, tablettenTiofarma B.V.
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Dapson Zentiva, Dapson-Fatol
- Denmark · Dapson Scanpharm
- United Kingdom (Northern Ireland) · Dapsone Macleods Pharma Uk, Dapsone Milpharm
- Malta · Dapsone Tillomed Laboratories
- Netherlands · Dapson Tiofarma
- Poland · Dusalm
- Portugal · Sulfona Zimaia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5a540f27-1dc1-49bb-9ed9-ad4c0b84511f GET /v1/drugs/5a540f27-1dc1-49bb-9ed9-ad4c0b84511f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Dapson",
"merkevare_id": "ID_D411175A-E6FB-4420-A5BD-C324148577B1",
"name_form_strength": "Dapson scanpharm tab 50 mg",
"prescription_group": "C"
}See everything about dapsone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.